SCHEMBL24601230

SCHEMBL24601230

CNNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(NCc4ccccn4)nc(-c4cncc(Cl)c4)nc32)O1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NT5E P21589 1/20 0.43
ADORA3 P0DMS8 11/20 0.42
ADORA2A P29274 4/20 0.39
ADORA1 P30542 4/20 0.39
ADORA2B P29275 2/20 0.39
KCNA5 P22460 1/20 0.38
KCNH2 Q12809 1/20 0.38
HTR2C P28335 1/20 0.38
PPARG P37231 1/20 0.38
HTR2B P41595 1/20 0.38
PPARD Q03181 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601006 0.95 ADORA3 (0.48) NT5EADORA3ADORA2AADORA1ADORA2B
SCHEMBL24601226 0.92 ADORA3 (0.44) NT5EADORA3ADORA2AADORA1ADORA2B
SCHEMBL24601236 0.92 ADORA3 (0.41) NT5EADORA3ADORA2AADORA1ADORA2B
SCHEMBL24601231 0.91 NT5E (0.42) NT5EADORA3ADORA2AADORA1ADORA2B
SCHEMBL24601108 0.91 ADORA3 (0.41) ADORA3ADORA2AADORA1ADORA2BHTR2C
SCHEMBL24601240 0.90 NT5E (0.42) NT5EADORA3ADORA2AADORA1ADORA2B
SCHEMBL24601261 0.90 ADORA3 (0.39) ADORA3ADORA2AADORA1ADORA2BHTR2C
SCHEMBL24601238 0.89 NT5E (0.42) NT5EADORA3ADORA2AADORA1ADORA2B
SCHEMBL30850581 0.88 ADORA3 (0.51) NT5EADORA3ADORA2AADORA1ADORA2B
SCHEMBL26628564 0.88 ADORA3 (0.51) NT5EADORA3ADORA2AADORA1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022143740-A1 ADENOSINE A3 RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF 浙江春禾医药科技有限公司 2022-07-07 WO disclosed